Cargando…

Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes

Currently, Non-Alcoholic Fatty Liver Disease (NAFLD) is the most prevalent form of chronic liver disease in children and adolescents worldwide. Simultaneously to the epidemic spreading of childhood obesity, the rate of affected young has dramatically increased in the last decades with an estimated p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scapaticci, Serena, D’Adamo, Ebe, Mohn, Angelika, Chiarelli, Francesco, Giannini, Cosimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056131/ https://www.ncbi.nlm.nih.gov/pubmed/33889132 http://dx.doi.org/10.3389/fendo.2021.639548

Ejemplares similares

Role of bile acids in overweight and obese children and adolescents
por: Giannini, Cosimo, et al.
Publicado: (2022)

Serum Levels of Receptors for Advanced Glycation End Products in Normal-Weight and Obese Children Born Small and Large for Gestational Age
por: Chiavaroli, Valentina, et al.
Publicado: (2012)

The Liver in Children With Metabolic Syndrome
por: D'Adamo, Ebe, et al.
Publicado: (2019)

Central Role of Fatty Liver in the Pathogenesis of Insulin Resistance in Obese Adolescents
por: D'Adamo, Ebe, et al.
Publicado: (2010)

Insulin Resistance in Children
por: Tagi, Veronica Maria, et al.
Publicado: (2019)

A Branched-Chain Amino Acid-Related Metabolic Signature Characterizes Obese Adolescents with Non-Alcoholic Fatty Liver Disease
por: Goffredo, Martina, et al.
Publicado: (2017)

Liver Steatosis: A Marker of Metabolic Risk in Children
por: Neri, Costanza Renata, et al.
Publicado: (2022)

Type 2 Diabetes in Youth: Epidemiology and Pathophysiology
por: D’Adamo, Ebe, et al.
Publicado: (2011)

The bad rainbow of COVID-19 time: effects on glucose metabolism in children and adolescents with obesity and overweight
por: Giannini, Cosimo, et al.
Publicado: (2022)

Clinical features and metabolic complications for non-alcoholic fatty liver disease (NAFLD) in youth with obesity
por: Barbieri, Emiliano, et al.
Publicado: (2023)

MAFLD and Celiac Disease in Children
por: Scapaticci, Serena, et al.
Publicado: (2023)

Insulin resistance relates to DKA severity and affects insulin requirement in children with type 1 diabetes at onset
por: Mastromauro, Concetta, et al.
Publicado: (2022)

Growth Abnormalities in Children with Type 1 Diabetes, Juvenile Chronic Arthritis, and Asthma
por: Giannini, Cosimo, et al.
Publicado: (2014)

Decreased Transcription of ChREBP-α/β Isoforms in Abdominal Subcutaneous Adipose Tissue of Obese Adolescents With Prediabetes or Early Type 2 Diabetes: Associations With Insulin Resistance and Hyperglycemia
por: Kursawe, Romy, et al.
Publicado: (2013)

Loss of Hepatic CEACAM1: A Unifying Mechanism Linking Insulin Resistance to Obesity and Non-Alcoholic Fatty Liver Disease
por: Heinrich, Garrett, et al.
Publicado: (2017)

Atherogenic Dyslipidemia and Cardiovascular Risk Factors in Obese Children
por: D'Adamo, Ebe, et al.
Publicado: (2015)

Evaluation of Bone Age in Children: A Mini-Review
por: Cavallo, Federica, et al.
Publicado: (2021)

Text Neck Syndrome in Children and Adolescents
por: David, Daniela, et al.
Publicado: (2021)

Prediction and Prevention of Type 1 Diabetes
por: Primavera, Marina, et al.
Publicado: (2020)

Short stature related to Growth Hormone Insensitivity (GHI) in childhood
por: Mastromauro, Concetta, et al.
Publicado: (2023)

Prevalence and risk factors for non-alcoholic fatty liver in children and youth with obesity
por: Jimenez-Rivera, Carolina, et al.
Publicado: (2017)

Single Point Insulin Sensitivity Estimator in Pediatric Non-Alcoholic Fatty Liver Disease
por: Furthner, Dieter, et al.
Publicado: (2022)

Hyperglycaemic hyperosmolar state in an obese prepubertal girl with type 2 diabetes: case report and critical approach to diagnosis and therapy
por: Mohn, Angelika, et al.
Publicado: (2021)

Thyroid Function and the Risk of Non-Alcoholic Fatty Liver Disease in Morbid Obesity
por: Borges-Canha, Marta, et al.
Publicado: (2020)

Lower Circulating Leptin Levels Are Related to Non-Alcoholic Fatty Liver Disease in Children With Obesity
por: Brandt, Stephanie, et al.
Publicado: (2022)

Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets
por: Chen, Yinshuang, et al.
Publicado: (2023)

Endotoxins and Non-Alcoholic Fatty Liver Disease
por: Kessoku, Takaomi, et al.
Publicado: (2021)

Connection of Nicotine to Diet-Induced Obesity and Non-Alcoholic Fatty Liver Disease: Cellular and Mechanistic Insights
por: Sinha-Hikim, Amiya P., et al.
Publicado: (2017)

Gut Dysfunction and Non-alcoholic Fatty Liver Disease
por: Grabherr, Felix, et al.
Publicado: (2019)

An update of the consensus statement on insulin resistance in children 2010
por: Tagi, Veronica Maria, et al.
Publicado: (2022)

Editorial: Obesity, Smoking, and Fatty Liver Disease
por: Sinha-Hikim, Amiya P., et al.
Publicado: (2018)

Association between the atherogenic index of plasma and new-onset non-alcoholic fatty liver disease in non-obese participants
por: Li, Kemin, et al.
Publicado: (2022)

Analysis of risk factors for non-alcoholic fatty liver disease in hospitalized children with obesity before the late puberty stage
por: Zhou, Lishan, et al.
Publicado: (2023)

Oxidation-Specific Epitopes in Non-Alcoholic Fatty Liver Disease
por: Hendrikx, Tim, et al.
Publicado: (2020)

Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease
por: Maruszczak, Katharina, et al.
Publicado: (2022)

Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
por: Rong, Li, et al.
Publicado: (2023)

ABCD1 gene mutation in an Italian family with X-linkedadrenoleukodystrophy: case series
por: Mohn, Angelika, et al.
Publicado: (2021)

Peculiar characteristics of new-onset Type 1 Diabetes during COVID-19 pandemic
por: Mastromauro, Concetta, et al.
Publicado: (2022)

Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD)
por: Cuthbertson, Daniel J., et al.
Publicado: (2021)

The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease
por: Grefhorst, Aldo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qb4fbbk0otlpb6nkbsgc80ahrf